Literature DB >> 23500344

The impact of temporary artery occlusion during intracranial aneurysm surgery on long-term clinical outcome: Part II. The patient who undergoes elective clipping.

Christoph J Griessenauer1, Tyler L Poston1, Mohammadali M Shoja2, Martin M Mortazavi1, Michael Falola1, R Shane Tubbs3, Winfield S Fisher1.   

Abstract

BACKGROUND: Temporary artery occlusion (TAO) during intracranial aneurysm surgery is a key element in facilitating aneurysm dissection and clipping. Despite its significance, knowledge of its effects on long-term clinical outcome in patients undergoing elective clipping for unruptured aneurysms is limited. This study evaluated the safety of this technique in this patient population by 1 surgeon.
METHODS: Patients managed for an intracranial aneurysm were followed from 2000-2009. This study included a cohort of patients found to have unruptured intracranial aneurysms who underwent TAO during their elective clipping procedure. Potential risk factors to affect outcome were considered. Effects of TAO on long-term clinical outcome were evaluated using the Glasgow Outcome Scale (GOS) obtained retrospectively by analyzing medical records at the last follow-up visit or discharge. Analyses included descriptive statistics, binary logistic regression, and ordinal logistic regression.
RESULTS: Inclusion criteria were met by 246 patients (75.2% female, age 54 years±10.9) with electively clipped, unruptured aneurysms. Mean follow-up was 53 months±67.5. Mean temporary artery clipping time was 16.1 minutes±14.7. Of patients, 86% had a good outcome and made a complete recovery at last follow-up (GOS 5); 9% of patients were moderately disabled (GOS 4); 5% of patients were severely disabled (GOS 3), were in a vegetative state (GOS 2), or had died (GOS 1). TAO time had no effects on overall long-term clinical outcomes (P=0.59). Although patients with posterior circulation aneurysms had a worse outcome compared with patients with anterior circulation aneurysms (P=0.008), age (P=0.176) and aneurysm size (P=0.497) were not significantly associated with clinical outcome.
CONCLUSIONS: This study did not demonstrate any relationship between limited duration of TAO and clinical outcome. Posterior circulation aneurysms are associated with worse long-term clinical outcomes in patients with electively clipped, unruptured aneurysms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Elective aneurysm clipping; Temporary artery occlusion

Mesh:

Year:  2013        PMID: 23500344     DOI: 10.1016/j.wneu.2013.02.067

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Update on transient cardiac standstill in cerebrovascular surgery.

Authors:  Leonardo Rangel-Castilla; Jonathan J Russin; Gavin W Britz; Robert F Spetzler
Journal:  Neurosurg Rev       Date:  2015-05-01       Impact factor: 3.042

2.  Efficacy of evoked potential monitoring for predicting postoperative motor status in internal carotid artery aneurysm surgeries.

Authors:  Hao You; Xing Fan; Dongze Guo; Zhibao Li; Xiaorong Tao; Lei Qi; Miao Ling; Jiajia Liu; Hui Qiao
Journal:  J Clin Monit Comput       Date:  2021-03-23       Impact factor: 1.977

3.  Clinical and morphological profile of aneurysms of the anterior communicating artery treated at a neurosurgical service in Southern Brazil.

Authors:  Fabiano Pasqualotto Soares; Maira Cristina Velho; Apio Claudio Martins Antunes
Journal:  Surg Neurol Int       Date:  2019-10-04

Review 4.  Optimal Use of Temporary Clip Application during Aneurysm Surgery - In Search of the Holy Grail.

Authors:  Sanjeev Kumar; Debabrata Sahana; Girish Menon
Journal:  Asian J Neurosurg       Date:  2021-05-28

5.  Intraoperative Combined Use of Somatosensory Evoked Potential, Microvascular Doppler Sonography, and Indocyanine Green Angiography in Clipping of Intracranial Aneurysm.

Authors:  Zhili Li; Guanni Zhang; Guangfu Huang; Zhengyu Wang; Haibin Tan; Jinping Liu; Aiguo Li
Journal:  Med Sci Monit       Date:  2016-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.